428 related articles for article (PubMed ID: 25480109)
1. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.
Trappanese DM; Liu Y; McCormick RC; Cannavo A; Nanayakkara G; Baskharoun MM; Jarrett H; Woitek FJ; Tillson DM; Dillon AR; Recchia FA; Balligand JL; Houser SR; Koch WJ; Dell'Italia LJ; Tsai EJ
Basic Res Cardiol; 2015 Jan; 110(1):456. PubMed ID: 25480109
[TBL] [Abstract][Full Text] [Related]
2. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
[TBL] [Abstract][Full Text] [Related]
3. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
Pat B; Killingsworth C; Denney T; Zheng J; Powell P; Tillson M; Dillon AR; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2321-7. PubMed ID: 18849331
[TBL] [Abstract][Full Text] [Related]
6. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
Angelone T; Filice E; Quintieri AM; Imbrogno S; Recchia A; Pulerà E; Mannarino C; Pellegrino D; Cerra MC
Acta Physiol (Oxf); 2008 Jul; 193(3):229-39. PubMed ID: 18208582
[TBL] [Abstract][Full Text] [Related]
7. β
Kawaguchi S; Okada M; Ijiri E; Koga D; Watanabe T; Hayashi K; Kashiwagi Y; Fujita S; Hasebe N
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H283-H294. PubMed ID: 31834837
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
Feng MG; Prieto MC; Navar LG
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F775-82. PubMed ID: 22674024
[TBL] [Abstract][Full Text] [Related]
9. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
11. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
Tallaj J; Wei CC; Hankes GH; Holland M; Rynders P; Dillon AR; Ardell JL; Armour JA; Lucchesi PA; Dell'Italia LJ
Circulation; 2003 Jul; 108(2):225-30. PubMed ID: 12847066
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
13. sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling.
Cawley SM; Kolodziej S; Ichinose F; Brouckaert P; Buys ES; Bloch KD
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H157-63. PubMed ID: 21536853
[TBL] [Abstract][Full Text] [Related]
14. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
15. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
16. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.
Bice JS; Burley DS; Baxter GF
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):269-82. PubMed ID: 24572031
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.
Sabri A; Rafiq K; Seqqat R; Kolpakov MA; Dillon R; Dell'italia LJ
Circ Res; 2008 May; 102(9):1127-36. PubMed ID: 18356543
[TBL] [Abstract][Full Text] [Related]
19. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
Chalimoniuk M; Chrapusta SJ; Lukačova N; Langfort J
Brain Res; 2015 Aug; 1618():29-40. PubMed ID: 26006108
[TBL] [Abstract][Full Text] [Related]
20. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage.
Ozakca I; Arioglu-Inan E; Esfahani H; Altan VM; Balligand JL; Kayki-Mutlu G; Ozcelikay AT
Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1267-76. PubMed ID: 23457011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
